leisure time -WSS

leisure time

author：leisure time 2025-09-03 14:41:57 - browse：2

A sign of The Cigna Group in front of trees with orange and green leaves — insurance overage from STAT — Joe Buglewicz/Bloomberg

Cigna and Humana are in discussions to merge, a potential move that would create a health insurance and prescription drug benefits titan with approximately $300 billion of annual revenue.

A proposed transaction would almost certainly prompt a close review from antitrust enforcers at the Department of Justice and the Federal Trade Commission. A merged Cigna-Humana would further consolidate the market for pharmacy benefit managers. PBMs are companies that serve as the controversial middlemen of drug pricing negotiations, and of the four largest, two are owned by Cigna and Humana.

The Wall Street Journal first reported the talks between Cigna and Humana on Wednesday, citing sources close to the situation. Wendell Potter, a health insurance whistleblower who used to work at Cigna, also wrote about merger discussions between Cigna and Humana on his blog Tuesday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Aspartame and sugar

knowledge

WSS

Will Ozempic

STAT Readout Newsletter: Today's biggest biotech updates

Hospitals are dialing back on venture capital investing

What to know about the judge who will handle the Trump case

Idaho college killings prosecutors challenge defense's grand jury claims

What to know about the judge who will handle the Trump case

focus

leisure time

knowledge

United colonoscopy coverage change 'may cost lives,' doctors say

The EU Joint Clinical Assessment needs to live up to its promise

Peter Hotez and the public health issue of online harassment

The EU Joint Clinical Assessment needs to live up to its promise

Medical leaders decry Supreme Court decision on affirmative action

STAT Summit: Biotech founders on deal

DIEP, the 'gold standard' of breast reconstruction, is under threat

YouTube cracks down on misinformation on cancer treatment

How one medical school became remarkably diverse

NIH confirmation hearing shows politicization of research

hotspot

Novo Nordisk touts Wegovy study, but still struggling with supply

CEOs share strategies for surviving biotech slump

Bird flu researchers hone in on Finland’s mink farms

How climate

First Opinion Podcast: Long Covid needs a new approach

2023 STAT Wunderkinds: get to know the winners

focus

knowledge

focus

Wikipedia